SEC Form 4 · accession 0001562180-16-002910
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Stambaugh
Officer — VP Clinical Affairs
Period of report
Aug 3, 2016
Accepted (ET)
Aug 5, 2016 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2016 | M | 3,977 | $0.48 | A | 27,977 | D | |
| Common Stock | Aug 3, 2016 | S | 3,977 | $17.00 | D | 24,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $0.48 | Aug 3, 2016 | M | 3,977 | D | — | Aug 21, 2017 | Common Stock | 3,977 | 10,716 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2016.
- F2The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning August 22, 2007.